CyberTRIZPEDIA

Supplier Validation Evidence vs Independent Verification

Run regulatory impact assessments during controlled pilots and expand vendor AI deployments only after documented compliance validation at each phase.

CyberTRIZ analysis · Pharma contradiction V007 · one of 8,235 worked contradictions published by CyberTRIZ.AI

Regulations

Business Context

Many pharmaceutical computerized systems are supplied by specialized software vendors that already perform extensive development testing, quality assurance, cybersecurity assessments, and documentation before releasing commercial products. Pharmaceutical organizations can leverage supplier documentation to reduce validation effort, yet they remain fully responsible for demonstrating that the system performs appropriately within their own regulated environment.

The Contradiction

Greater reliance on supplier documentation reduces validation effort. Greater independent verification increases confidence in intended use.

Why It Exists

Organizations frequently repeat supplier testing unnecessarily because they lack structured methodologies for evaluating supplier quality systems and determining which evidence can be accepted.

Applying Pharmatriz

Supplier assessments should become an integral component of validation planning. Reliable supplier evidence may replace redundant testing while organization-specific qualification focuses on configuration, intended use, interfaces, security, and operational performance.

Solution Directions

TRIZ principles applied

P03 Local QualityP05 MergingP20 Continuity of Useful Action